Total Payments
$531,062
2024 Payments
$41,667
Companies
56
Transactions
613
Medicare Patients
3,285
Medicare Billing
$297,948
Payment Breakdown by Category
Other$327,828 (61.7%)
Consulting$100,119 (18.9%)
Travel$90,691 (17.1%)
Food & Beverage$12,088 (2.3%)
Education$335.94 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $327,428 | 108 | 61.7% |
| Consulting Fee | $100,119 | 47 | 18.9% |
| Travel and Lodging | $90,691 | 124 | 17.1% |
| Food and Beverage | $12,088 | 329 | 2.3% |
| Honoraria | $400.00 | 1 | 0.1% |
| Education | $335.94 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $164,452 | 179 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $154,256 | 111 | $0 (2018) |
| Janssen Biotech, Inc. | $103,387 | 106 | $0 (2024) |
| PFIZER INC. | $62,357 | 66 | $0 (2023) |
| Medtronic, Inc. | $10,634 | 12 | $0 (2024) |
| Myovant Sciences Inc. | $10,616 | 8 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $5,720 | 9 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $5,350 | 3 | $0 (2023) |
| Lutonix, Inc. | $4,150 | 3 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,841 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41,667 | 66 | Janssen Biotech, Inc. ($34,980) |
| 2023 | $9,698 | 36 | Medtronic, Inc. ($5,534) |
| 2022 | $30,416 | 47 | Janssen Biotech, Inc. ($14,721) |
| 2021 | $38,393 | 30 | Astellas Pharma US Inc ($17,711) |
| 2020 | $36,979 | 32 | Astellas Pharma US Inc ($26,084) |
| 2019 | $88,388 | 103 | Astellas Pharma US Inc ($26,298) |
| 2018 | $194,919 | 197 | Janssen Scientific Affairs, LLC ($127,890) |
| 2017 | $90,603 | 102 | Astellas Pharma US Inc ($40,908) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $144.15 | General |
| Category: Oncology | ||||||
| 12/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $1,139.20 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $50.94 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 10/28/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Urology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Ambu A/S | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $131.25 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 09/10/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $27.42 | General |
| 09/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $123.31 | General |
| Category: Oncology | ||||||
| 08/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,070.00 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $1,236.84 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $1,193.60 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 900 | 1,093 | $455,125 | $84,632 |
| 2022 | 20 | 853 | 1,006 | $462,460 | $80,668 |
| 2021 | 15 | 805 | 965 | $322,236 | $74,943 |
| 2020 | 15 | 727 | 884 | $272,768 | $57,706 |
Total Patients
3,285
Total Services
3,948
Medicare Billing
$297,948
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 159 | 195 | $74,309 | $14,201 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 61 | 75 | $39,743 | $8,692 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 56 | $21,340 | $6,026 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 84 | 107 | $28,812 | $5,805 | 20.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 61 | 96 | $70,200 | $5,552 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 64 | $17,233 | $4,893 | 28.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 20 | 21 | $15,356 | $4,529 | 29.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 28 | $14,837 | $4,403 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $15,201 | $4,313 | 28.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 23 | $36,612 | $3,193 | 8.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 11 | 13 | $10,958 | $3,188 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $12,926 | $2,972 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 33 | 33 | $16,182 | $2,928 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $10,341 | $2,733 | 26.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 24 | 24 | $18,295 | $2,524 | 13.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 35 | $7,459 | $2,188 | 29.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 28 | 38 | $4,280 | $1,581 | 36.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 12 | 12 | $11,499 | $1,550 | 13.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 19 | 19 | $5,552 | $1,360 | 24.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 24 | 24 | $13,297 | $667.68 | 5.0% |
| 51702 | Simple insertion of temporary bladder tube | Facility | 2023 | 25 | 28 | $5,504 | $535.75 | 9.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 88 | 107 | $963.00 | $364.87 | 37.9% |
| 51700 | Simple bladder irrigation and/or instillation | Facility | 2023 | 12 | 15 | $3,648 | $308.64 | 8.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 13 | 13 | $577.85 | $123.84 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 223 | 287 | $107,821 | $21,635 | 20.1% |
About Dr. Tony Luongo, MD
Dr. Tony Luongo, MD is a Urology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164520417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tony Luongo, MD has received a total of $531,062 in payments from pharmaceutical and medical device companies, with $41,667 received in 2024. These payments were reported across 613 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($327,428).
As a Medicare-enrolled provider, Luongo has provided services to 3,285 Medicare beneficiaries, totaling 3,948 services with total Medicare billing of $297,948. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Boston, MA
- Active Since 09/20/2006
- Last Updated 09/22/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1164520417
Products in Payments
- Erleada (Drug) $158,834
- XTANDI (Drug) $152,356
- ERLEADA (Drug) $67,120
- DARZALEX (Biological) $26,365
- Xtandi (Drug) $16,305
- ORGOVYX (Drug) $9,316
- LUTONIX (Device) $5,625
- Non-Covered (Drug) $1,841
- OES CHOLEDOCHOFIBERSCOPE (Device) $1,620
- Enzalutamide (Drug) $1,159
- YONSA (Drug) $500.00
- JEVTANA (Drug) $350.00
- Myrbetriq (Drug) $221.62
- ELIGARD (Drug) $214.69
- MYRBETRIQ (Drug) $149.43
- JELMYTO (Drug) $139.82
- ADSTILADRIN (Biological) $128.77
- Axumin (Drug) $126.16
- Prolia (Biological) $125.40
- NOCDURNA (Drug) $89.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Boston
Dr. Christopher Cutie, Md, MD
Urology — Payments: $3.8M
Urology $3.8M
Brian Eisner, Md, MD
Urology — Payments: $594,130
Urology $594,130
Dr. Shahin Tabatabaei, Md, MD
Urology — Payments: $165,699
Urology $165,699
Ricardo Munarriz, M.d, M.D
Urology — Payments: $138,151
Urology $138,151
Richard Babayan, M.d, M.D
Urology — Payments: $115,932
Urology $115,932
Dr. Adam Kibel, Md, MD
Urology — Payments: $113,326
Urology $113,326